The general public will subscribe 6.25 million shares, 25 percent of the total offer size of BF Biosciences IPO on October 2nd and 3rd at the strike price of Rs 77.
The general public can subscribe the IPO on 2nd and 3rd October from 9.00 am to 5pm during banking hours. However, in the case of e-IPO, the process continues for 24 hours.
BF Biosciences IPO Receives Overwhelming Response from Investors
The book-building phase of BF Biosciences concluded last week with an oversubscription of 3.4 times.
The IPO received an overwhelming response from institutional investors and high-net worth individuals as the strike price clocked in at Rs 77/share, 40 percent higher than the floor price of Rs 55 and raised Rs 1.93 billion.
Shahid Ali, CEO Arif Habib Limited said that investing in the public offering of BF Biosciences presents a decent opportunity for retail investors to engage with a fundamentally strong company at a more attractive valuation compared to the broader pharmaceutical sector.
This unique positioning allows investors to capitalize on potential growth while benefiting from a favorable entry point.
Prime Minister Shehbaz Sharif announced on Sunday the complete elimination of the PTV licence fee…
The Aga Khan University Examination Board (AKU-EB) has successfully concluded a capacity development and technical…
In a landmark decision, the Universal Service Fund's (USF) Board of Directors has greenlit seven…
Pakistan’s passport has made a notable leap in global mobility rankings, entering the top 100…
An international survey conducted across 17 total countries, including Pakistan, was commissioned by the Global…
Data Vault Pakistan has officially launched the country’s first AI-focused data center in Karachi, a…
This website uses cookies.
